Aarti Pharmalabs Ltd
Aarti Pharmalabs's Climate Target Data Preview
As of 2025, Aarti Pharmalabs has disclosed 4 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 4 absolute reduction targets, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Aarti Pharmalabs's climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target* | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy/Paste is a PRO feature.  a | 2030 |
Absolute-based Target | Scope 3 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | 0000000 | 2030 |
Absolute-based Target* | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy/Paste is a PRO feature.  a | 2050 |
Absolute-based Target | Scope 3 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | 0000000 | 2050 |
Verified Sources Behind Aarti Pharmalabs’s Climate Targets Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Aarti Pharmalabs’s data sources below and access millions more through our Disclosure Search.
Insights into Aarti Pharmalabs's Greenhouse Gas Emissions Pathways
As of 2025, Aarti Pharmalabs has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.a
Does Aarti Pharmalabs have a target to reduce the emissions from its operations?
As of 2025, Aarti Pharmalabs has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.a
Aarti Pharmalabs's most ambitious operational target is to reduce these emissions by 90% by 2050, compared to a baseline of 157,048.91 Metric Tonnes of CO2 equivalent (mtCO2e) in 2024.a
Instead of reducing operational emissions, Aarti Pharmalabs has increased them, with 2025 levels exceeding those of the 2024 baseline, placing the company well behind its reduction target.a